Publication activity
Total number of publications: 63
Articles
-
Dávno překonaný, ale stále používaný - spotřeby fenobarbitalu v magistraliter přípravě
Česká a slovenská farmacie, year: 2024, volume: 73, edition: 1
-
Development of a New Bioequivalent Omeprazole Product
Medicina-Lithuania, year: 2024, volume: 60, edition: 3, DOI
-
Dibenzocyclooctadiene Lignans from Schisandra chinensis with Anti-Inflammatory Effects
International Journal of Molecular Sciences, year: 2024, volume: 25, edition: 6, DOI
-
Disruption of Lipid Profile, Glucose Metabolism, and Leptin Levels following Citalopram Administration and High-Carbohydrate and High-Cholesterol Diet in Mice
PHARMACOLOGY, year: 2024, volume: Neuveden, edition: Neuvedeno, DOI
-
Diterpenes Isolated from Three Different Plectranthus Sensu Lato Species and Their Antiproliferative Activities against Gynecological and Glioblastoma Cancer Cells
ACS Omega, year: 2024, volume: 9, edition: 16, DOI
-
Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, year: 2024, volume: Neuveden, edition: 7, DOI
-
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice
Frontiers in Medicine, year: 2024, volume: 10, edition: January 2024, DOI
-
Enhancing Solubility and Bioefficacy of Stilbenes by Liposomal Encapsulation-The Case of Macasiamenene F
ACS Omega, year: 2024, volume: 9, edition: 8, DOI
-
Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study
Journal of bone and mineral research, year: 2024, volume: 39, edition: 3, DOI
-
Farmakologický profil erdosteinu - známá molekula - nové efekty
Česká a Slovenská Farmacie, year: 2024, volume: 2024 (73), edition: 1
doplnit text